2026-2034年慢性靜脈阻塞治療全球市場規模、佔有率、趨勢和成長分析報告

預計慢性靜脈阻塞治療市場規模將從 2025 年的 78.4 億美元成長到 2034 年的 126.2 億美元，2026 年至 2034 年的複合年成長率為 5.43%。

由於深層靜脈栓塞症、血栓後症候群和其他靜脈疾病的盛行率不斷上升，全球慢性靜脈阻塞治療市場正經歷穩定成長。人口老化和久坐的生活方式是造成全球慢性靜脈阻塞負擔的重要因素。微創血管內治療技術的進步，包括導管導引溶栓和支架置入術，正在改善患者預後，並推動治療方法在已開發經濟體和新興經濟體的應用。

成長要素包括公眾健康意識的提高、診斷影像技術的進步以及發展中地區醫療基礎設施的擴張。隨著患者越來越希望縮短住院時間、加速康復，對高效能微創治療方法的需求也日益成長。此外，多個國家優惠的健保報銷政策正在加速醫院和專科診所採用先進的靜脈介入設備和治療方法。

展望未來，藥物釋放型支架和影像引導介入系統等技術創新預計將對市場產生正面影響。臨床研究的增加以及醫療設備製造商與醫療服務提供者之間合作的加強有望提高手術成功率。隨著早期診斷的廣泛應用和患者意識的提高，預計在整個預測期內市場將持續擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球慢性靜脈阻塞治療市場：依產品分類

• 市場分析、洞察與預測
• 裝置
• 製藥

第5章 全球慢性靜脈阻塞治療市場：依應用領域分類

• 市場分析、洞察與預測
• 靜脈曲張

第6章 全球慢性靜脈阻塞治療市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 其他最終用戶

第7章 全球慢性靜脈阻塞治療市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Bayer AG
  • Boston Scientific Corporation
  • Bristol Myers Squibb
  • Candela
  • ConvaTec Inc
  • Fotona
  • Julius Zorn GmbH
  • Leucadia Pharmaceuticals（Hikma）
  • Lumenis Ltd
  • Medi GmbH & Co. KG
  • Medtronic Plc
  • Merz Pharma
  • Pfizer Inc
  • Sanofi

The Chronic Venous Occlusions Treatment Market size is expected to reach USD 12.62 Billion in 2034 from USD 7.84 Billion (2025) growing at a CAGR of 5.43% during 2026-2034.

The Global Chronic Venous Occlusions Treatment Market is experiencing steady growth due to the rising prevalence of deep vein thrombosis, post-thrombotic syndrome, and other venous disorders. Increasing aging populations and sedentary lifestyles have contributed significantly to the burden of chronic venous occlusions worldwide. Advancements in minimally invasive endovascular procedures, including catheter-directed thrombolysis and stent placement, are enhancing patient outcomes and expanding treatment adoption across developed and emerging economies.

Key growth drivers include growing awareness about venous health, improved diagnostic imaging technologies, and expanding healthcare infrastructure in developing regions. The demand for effective, less invasive treatment options is increasing as patients prefer shorter hospital stays and faster recovery times. Additionally, favorable reimbursement policies in several countries are encouraging hospitals and specialty clinics to adopt advanced venous intervention devices and therapies.

Looking ahead, the market is expected to benefit from technological innovations such as drug-eluting stents and image-guided intervention systems. Increasing clinical research and collaborations between medical device companies and healthcare providers will likely improve procedural success rates. As early diagnosis becomes more common and patient awareness rises, the market is projected to witness sustained expansion over the forecast period.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Devices
• Drugs

By Application

• Varicose veins

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Other End-Users

COMPANIES PROFILED

• 3M Company, , Bayer AG, Boston Scientific Corporation, Bristol Myers Squibb, Candela, ConvaTec Inc, Fotona, Julius Zorn GmbH, Leucadia Pharmaceuticals Hikma, Lumenis Ltd, Medi GmbH Co KG, Medtronic plc, Merz Pharma, Pfizer Inc, Sanofi
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Varicose veins Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Bayer AG
  • 9.2.2 Boston Scientific Corporation
  • 9.2.3 Bristol Myers Squibb
  • 9.2.4 Candela
  • 9.2.5 ConvaTec Inc
  • 9.2.6 Fotona
  • 9.2.7 Julius Zorn GmbH
  • 9.2.8 Leucadia Pharmaceuticals (Hikma)
  • 9.2.9 Lumenis Ltd
  • 9.2.10 Medi GmbH & Co. KG
  • 9.2.11 Medtronic Plc
  • 9.2.12 Merz Pharma
  • 9.2.13 Pfizer Inc
  • 9.2.14 Sanofi